European Heart Journal Supplements最新文献

The May Measurement Month (MMM) campaign was carried out in the Philippines in 2022 with the aim of raising awareness of raised blood pressure (BP). Here, we report on the findings of the campaign. Adults aged ≥18 years were recruited opportunistically at hospitals, doctor's clinics, health centres under local government units, private companies (pharmaceutical companies and corporates), drug stores, and others. Three seated BP readings were taken for each participant, along with the completion of a questionnaire on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg or being on antihypertensive medication. Controlled BP was defined as being on antihypertensive medication with a BP <140/90 mmHg. Multiple imputation was used to estimate any missing BP readings. In total, 42 526 were screened, with a mean age of 46.0 years, and 59.9% were female. Of all participants, 18 390 (43.2%) had hypertension, of whom 13 144 (71.5%) were aware, and 11 738 (63.8%) were on antihypertensive medication. Of those on antihypertensive medication, 2792 (23.8%) had controlled BP, and of all participants with hypertension, 15.2% had controlled BP. The MMM campaign in the Philippines identified significant numbers of participants with either untreated or inadequately treated hypertension. The campaign resulted in higher awareness with regard to hypertension diagnosis, treatment, and control.

The May Measurement Month (MMM) campaign was carried out in Paraguay in 2022 with the aim of raising awareness in the population of increased blood pressure (BP). Adults aged ≥18 years were recruited opportunistically in the country. Three BP readings were taken for each participant, along with completion of a questionnaire on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg or being treated with antihypertensive medication. Controlled BP was defined as being on antihypertensive medication with a BP < 140/90 mmHg. Multiple imputation was used to estimate any missing BP readings. In total, 10 475 adults were screened, with a mean age of 48.6 years, and 62.0% were female. Most (57.3%) of the participants were screened in health service settings. Of all participants, 6049 (57.7%) had hypertension, 4367 (72.2%) were aware, 4246 (70.2%) were on antihypertensive medication, of whom 1686 (39.7%) had controlled BP, and of all participants with hypertension 27.9% had controlled BP. Hypertension was more common in male than in female participants (60.1 vs. 56.3%), and male hypertensive participants were less often controlled (21.5 vs. 32.0%). In conclusion, this campaign identified significant numbers of participants with hypertension and a great number on treatment who did not have controlled BP.

The May Measurement Month (MMM) campaign was carried out in the UK and Republic of Ireland (RoI) in 2022 with the aim of raising awareness of raised blood pressure (BP). Here, we report on the findings of the campaign. Adults aged ≥18 years were recruited opportunistically at hospitals, general practice surgeries, community pharmacies, universities, gyms, and various other public places. Three seated BP readings were taken on each participant, along with completion of a questionnaire on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg or being on antihypertensive medication. Controlled BP was defined as being on antihypertensive medication with a BP < 140/90 mmHg. Multiple imputation was used to estimate any missing BP readings. In total, 3034 were screened, with a mean age of 55.2 (19.0) and 60.2% of whom were female. Of all participants, 1506 (49.6%) had hypertension, of whom 876 (58.2%) were aware, and 798 (53.0%) were on antihypertensive medication. Of those on antihypertensive medication, 382 (47.9%) had controlled BP, and of all participants with hypertension, 25.4% had controlled BP. The proportion of hypertension was similar between males and females, but females had better awareness, greater use of antihypertensive medication, and better medication-controlled BP than males. The MMM campaign in the UK and RoI identified significant numbers of participants with either untreated or inadequately treated hypertension. This evidence underscores the critical need for more effective strategies to improve BP detection and control in order to reduce the significant public health challenge and overall disease burden of hypertension.

The May Measurement Month (MMM) campaign was carried out in Slovenia in 2022 with the aim of raising awareness of raised blood pressure (BP). Here, we report on the findings of the campaign. Adults aged ≥18 years were recruited opportunistically mainly at pharmacies and health care facilities across all regions of the country and in some public places (such as the sports event Tek ob žici). Three seated BP readings were taken for each participant, along with completion of a questionnaire on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg or being on antihypertensive medication. Controlled BP was defined as being on antihypertensive medication with a BP < 140/90 mmHg. Multiple imputation was used to estimate any missing BP readings. In total, 2181 were screened, with a mean age of 59.2 years and 62.2% of whom were female. Of all participants, 1154 (52.9%) had hypertension, of whom 880 (76.3%) were aware, and 683 (59.2%) were on antihypertensive medication. Of those on antihypertensive medication, 333 (48.8%) had controlled BP, and of all participants with hypertension, 28.9% had controlled BP. Of all those screened, 263 (12.1%) participants had diabetes, 59 (2.7%) a history of stroke, and 61 (2.8%) a history of myocardial infarction. The MMM campaign in Slovenia identified significant numbers of participants with either untreated or inadequately treated hypertension. All were given healthy lifestyle advice and were referred to their general practitioners for further evaluation and treatment.

In Bangladesh, about one in four adults aged 18-69 years are hypertensive. Nationwide periodic blood pressure (BP) screening campaigns are helpful in identifying undiagnosed patients. The May Measurement Month (MMM) campaign was carried out in Bangladesh in 2022 with the aim of raising awareness of raised BP. Here, we report on the findings of the campaign. Adults aged ≥18 years were recruited opportunistically at 100 screening sites in 27 districts in Bangladesh. Three seated BP readings were taken for each participant, along with the completion of a questionnaire on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg or being on antihypertensive medication. Controlled BP was defined as being on antihypertensive medication with a BP <140/90 mmHg. Multiple imputation was used to estimate any missing BP readings. In total, 16 544 were screened, with a mean age of 47.4 years and 51.7% of whom were female. Of all participants, 9654 (58.4%) had hypertension, of whom 8593 (89.0%) were aware, and 8087 (83.8%) were on antihypertensive medication. Of those on antihypertensive medication, 4014 (49.6%) had controlled BP, and of all participants with hypertension, 41.6% had controlled BP. The MMM campaign in Bangladesh identified significant numbers of participants with either untreated or inadequately treated hypertension. Ensuring effective detection and treatment of raised BP is one of the most cost-effective ways to prevent death and disability due to high BP.

High blood pressure (BP) continues to be the leading cause of disability and death in the world over the years. With an unacceptably low rate of diagnosis and control, it challenges health systems in most countries. Thus, the Argentine Society of Arterial Hypertension (SAHA), in accordance with the May Measurement Month (MMM) initiative of the International Society of Hypertension, implemented for the sixth consecutive year a high BP detection campaign. A voluntary cross-sectional survey was conducted in public spaces and health centres during the month of May 2022. Hypertension was defined as systolic BP of ≥140 mmHg and/or diastolic BP of ≥90 mmHg based on the second of two BP measurements, or in those receiving treatment for high BP. In total, 50 746 participants were examined, with a mean age of 54.8 (standard deviation 17.1) and 61.1% of whom were women. Of all participants, 30 361 (59.8%) had hypertension, of which 22 933 (75.5%) were aware, 21 997 (72.4%) were taking antihypertensive medication, and 10 116 (33.3%) were controlled to <140/90 mmHg. The mean BP was 131.7/80.4 (±20.8/±12.7) mmHg. After standardization by age and sex, 23 094 (45.5%) were found to have hypertension, of which 14 270 (61.8%) were aware of it. The poor level of hypertension control that is repeated over the years exposes insufficient efforts and ineffective strategies that should generate different approaches in both the medical field and in the community that reinforce strategies to increase awareness and control of hypertension.

The May Measurement Month (MMM) campaign was carried out in Thailand in 2022 with the aim of raising awareness of raised blood pressure (BP). Here, we report on the findings of the campaign. Adults aged ≥18 years were recruited opportunistically at hospitals and co-working spaces in all regions of Thailand. Three seated BP readings were taken for each participant, along with the completion of a questionnaire on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg or being on antihypertensive medication. Controlled BP was defined as being on antihypertensive medication with a BP < 140/90 mmHg. Multiple imputation was used to estimate any missing BP readings. In total, 10 562 were screened, with a mean age of 50.4 years and 60.8% of whom were female. Of all participants, 4670 (44.2%) had hypertension, of whom 3416 (73.1%) were aware, and 3240 (69.4%) were on antihypertensive medication. Of those on antihypertensive medication, 1957 (60.4%) had controlled BP, and of all participants with hypertension, 41.9% had controlled BP. The MMM campaign in Thailand identified significant numbers of participants with either untreated or inadequately treated hypertension. Appropriate intervention after BP screening together with prescribing suitable BP-lowering regimens should be implemented to enhance BP control.

The May Measurement Month (MMM) campaign was carried out in China in 2022 with the aim of raising awareness of raised blood pressure (BP). Here, we report the findings of the campaign. Adults aged ≥18 years were recruited opportunistically at 30 China provinces. Three seated BP readings were taken for each participant, along with completion of a questionnaire on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg or being on antihypertensive medication. Controlled BP was defined as being on antihypertensive medication with a BP <140/90 mmHg. Multiple imputation was used to estimate any missing BP readings. In total, 188 975 were screened, with a mean age of 46.0 years, and 49.6% of whom were female. Of all participants, 49 788 (26.3%) had hypertension, of whom 11 268 (22.6%) were aware, and 10 945 (22.0%) were on antihypertensive medication. Of those on antihypertensive medication, 6362 (58.1%) had controlled BP, and of all participants with hypertension, 12.8% had controlled BP. After adjustment for age, sex, and use of antihypertensive medication, both systolic and diastolic BP were significantly (P ≤ 0.01) higher in those drinking alcohol 1-3 times per month (n = 24322, + 0.7/+0.4 mmHg) and higher still BPs in those drinking 1-6 times per week (n = 10691, +2.9/+1.0 mmHg) compared with those who never or rarely drank alcohol. In total, 43 426 (23.0%) were found to have either untreated or inadequately treated hypertension. The MMM campaign in China identified particularly high rates of untreated hypertension and also inadequately treated hypertension, which should inform strategies to improve the detection and management of hypertension in China.

The May Measurement Month (MMM) campaign was carried out in Ghana in 2022 with the aim of raising awareness of raised blood pressure (BP). Here, we report on the findings of the campaign. Adults aged ≥ 18 years were recruited opportunistically at Greater Accra, Eastern, Central, and Ashanti Regions of Ghana. Three seated BP readings were taken for each participant, along with completing a questionnaire on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg or being on antihypertensive medication. Controlled BP was defined as being on antihypertensive medication with a BP <140/90 mmHg. Multiple imputation was used to estimate any missing BP readings. In total, 3654 were screened, with a mean age of 38.3 years and 14.8% of whom were female. Of all participants, 1171 (32.0%) had hypertension, of whom 125 (10.7%) were aware, and 118 (10.1%) were on antihypertensive medication. Of those on antihypertensive medication, 23 (19.5%) had controlled BP, and of all participants with hypertension, 2.0% had controlled BP. The MMM campaign in Ghana identified a high proportion of participants with either untreated or inadequately treated hypertension. It is important to note that the annual BP screening campaign is a means to create awareness of the need to get screened and also identifies large numbers of individuals with raised BP.